VIMTALABS.BO BSE

Established in 1984 and headquartered in Hyderabad, India, Vimta Labs Limited operates as a leading provider of contract research and testing services, serving clients both domestically and across international markets. The company offers an extensive range of analytical and scientific support, covering the entire product lifecycle from initial discovery and development through to post-market approval. Their comprehensive services encompass preclinical and early development studies, clinical research and development, and complete drug life cycle management. Vimta Labs also specializes in bioanalytical, analytical, and central laboratory services, alongside testing for genetically modified organisms (GMOs) and clinical diagnostics. Further areas of expertise include environmental testing, food product analysis, analytical method development, and electromagnetic interference/compatibility (EMI/EMC) testing. Additionally, the company performs specialized investigations such as IND/505 (b)(2) enabling studies, in vitro permeation (IVPT), release (IVRT), and bioequivalence (IVBE) assessments. They conduct detailed analyses for various substances, including dioxins and furans, trace heavy metals, radioactive isotopes, vitamins, minerals, and also evaluate label claims, packaging integrity, and product shelf life. Vimta Labs caters to a diverse array of industries, including pharmaceuticals, biologics and biosimilars, medical devices, nutraceuticals, food and beverages, agriculture and crop care, specialty chemicals, home and personal care, electricals and electronics, and environmental health and safety.